NUMA1 and breast cancer: Other FDA-approved alternatives to urinary cytology for the initial detection and surveillance of BC include the nuclear matrix protein 22 (NMP22) kit, NMP22, and UroVysion, which are also mentioned in the European Urological Guidelines, the BladderChek Test, BTA-TRAK and BTA stat kits, and Cell Search.